Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.

There is no fulltext present in this item.

Title:	Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.
Author(s):	Witte, J.H. de ; Sweep, C.G.J. ; Klijn, J.G.M.; Grebenchtchikov, N.J. ; Peters, H.A. ; Look, M.P.; Tienoven, T.H. van ; Heuvel, J.J.T.M. ; Putten, W.L.J. van; Benraad, T.J. ; Foekens, J.A.
Publication year:	1999
Source:	British Journal of Cancer, vol. 79, iss. 7/8, (1999), pp. 1190-1198
ISSN:	0007-0920
DOI:	https://doi.org/10.1038/sj.bjc.6690191
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/184847
Display more details
Subject:	Development of assays for prognostic factors in oncological endocrinology Ontwikkeling van meetmethodes voor prognostische factoren in de oncologische endocrinologie
Organization:	Chemical Endocrinology
Journal title:	British Journal of Cancer
Volume:	vol. 79
Issue:	iss. 7/8
Page start:	p. 1190
Page end:	p. 1198